MN Stat § 152.22 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.22 — Definitions.

152.22 DEFINITIONS. Subdivision 1. Applicability. For purposes of sections 152.22 to 152.37, the terms defined in this section have the meanings given them. Subd. 2. Commissioner. "Commissioner" means the commissioner of health. Subd. 3. Disqualifying felony offense. "Disqualifying felony offense" means a violation of a state or federal controlled substance law that is a felony under Minnesota law, or would be a felony if committed in Minnesota, regardless of the sentence imposed, unless the commissioner determines that the person's conviction was for the medical use of cannabis or assisting with the medical use of cannabis. Subd. 4. Health care practitioner. "Health care practitioner" means a Minnesota licensed doctor of medicine, a Minnesota licensed physician assistant acting within the scope of authorized practice, or a Minnesota licensed advanced practice registered nurse who has the primary responsibility for the care and treatment of the qualifying medical condition of a person diagnosed with a qualifying medical condition. Subd. 5. Health records. "Health records" means health records as defined in section 144.291, subdivision 2, paragraph (c). Subd. 5a. Hemp. "Hemp" has the meaning given to industrial hemp in section 18K.02, subdivision 3. Subd. 5b. Hemp grower. "Hemp grower" means a person licensed by the commissioner of agriculture under chapter 18K to grow hemp for commercial purposes. Subd. 5c. Hemp processor. "Hemp processor" means a person or business licensed by the commissioner of agriculture under chapter 18K to convert raw hemp into a product. Subd. 6. Medical cannabis. (a) "Medical cannabis" means any species of the genus cannabis plant, or any mixture or preparation of them, including whole plant extracts and resins, and is delivered in the form of: (1) liquid, including, but not limited to, oil; (2) pill; (3) vaporized delivery method with use of liquid or oil; (4) combustion with use of dried raw cannabis; or (5) any other method approved by the commissioner. (b) This definition includes any part of the genus cannabis plant prior to being processed into a form allowed under paragraph (a), that is possessed by a person while that person is engaged in employment duties necessary to carry out a requirement under sections 152.22 to 152.37 for a registered manufacturer or a laboratory under contract with a registered manufacturer. This definition also includes any hemp acquired by a manufacturer by a hemp grower as permitted under section 152.29, subdivision 1, paragraph (b). [See Note.] Subd. 7. Medical cannabis manufacturer. "Medical cannabis manufacturer" or "manufacturer" means an entity registered by the commissioner to cultivate, acquire, manufacture, possess, prepare, transfer, transport, supply, or dispense medical cannabis, delivery devices, or related supplies and educational materials. Subd. 8. Medical cannabis product. "Medical cannabis product" means any delivery device or related supplies and educational materials used in the administration of medical cannabis for a patient with a qualifying medical condition enrolled in the registry program. Subd. 9. Patient. "Patient" means a Minnesota resident who has been diagnosed with a qualifying medical condition by a health care practitioner and who has otherwise met any other requirements for patients under sections 152.22 to 152.37 to participate in the registry program under sections 152.22 to 152.37. Subd. 10. Patient registry number. "Patient registry number" means a unique identification number assigned by the commissioner to a patient enrolled in the registry program. Subd. 11. Registered designated caregiver. "Registered designated caregiver" means a person who: (1) is at least 18 years old; (2) does not have a conviction for a disqualifying felony offense; (3) has been approved by the commissioner to assist a patient who requires assistance in administering medical cannabis or obtaining medical cannabis from a distribution facility; and (4) is authorized by the commissioner to assist the patient with the use of medical cannabis. Subd. 12. Registry program. "Registry program" means the patient registry established in sections 152.22 to 152.37. Subd. 13. Registry verification. "Registry verification" means the verification provided by the commissioner that a patient is enrolled in the registry program and that includes the patient's name, registry number, and, if applicable, the name of the patient's registered designated caregiver or parent, legal guardian, or spouse. Subd. 14. Qualifying medical condition. "Qualifying medical condition" means a diagnosis of any of the following conditions: (1) cancer, if the underlying condition or treatment produces one or more of the following: (i) severe or chronic pain; (ii) nausea or severe vomiting; or (iii) cachexia or severe wasting; (2) glaucoma; (3) human immunodeficiency virus or acquired immune deficiency syndrome; (4) Tourette's syndrome; (5) amyotrophic lateral sclerosis; (6) seizures, including those characteristic of epilepsy; (7) severe and persistent muscle spasms, including those characteristic of multiple sclerosis; (8) inflammatory bowel disease, including Crohn's disease; (9) terminal illness, with a probable life expectancy of under one year, if the illness or its treatment produces one or more of the following: (i) severe or chronic pain; (ii) nausea or severe vomiting; or (iii) cachexia or severe wasting; or (10) any other medical condition or its treatment approved by the commissioner. History: 2014 c 311 s 2; 2015 c 74 s 2; 2016 c 179 s 27; 1Sp2019 c 9 art 11 s 78-82; 2021 c 30 art 3 s 28-30 NOTE: The amendment to subdivision 6 by Laws 2021, chapter 30, article 3, section 29, is effective the earlier of (1) March 1, 2022, or (2) a date, as determined by the commissioner of health, by which (i) the rules adopted or amended under Minnesota Statutes, section 152.26, paragraph (b), are in effect, and (ii) the independent laboratories under contract with the manufacturers have the necessary procedures and equipment in place to perform the required testing of dried raw cannabis. If this section is effective before March 1, 2022, the commissioner shall provide notice of that effective date to the public. Laws 2021, chapter 30, article 3, section 29, the effective date.